PA
Profund Advisors Portfolio holdings
AUM
$2.78B
1-Year Return
29.53%
This Quarter Return
+14.4%
1 Year Return
+29.53%
3 Year Return
+153.44%
5 Year Return
+262.59%
10 Year Return
+738.89%
AUM
$1.62B
AUM Growth
+$77.5M
(+5%)
Cap. Flow
-$75.6M
Cap. Flow
% of AUM
-4.67%
Top 10 Holdings %
Top 10 Hldgs %
28.88%
Holding
1,192
New
187
Increased
321
Reduced
580
Closed
103
Top Buys
| 1 |
NVIDIA
NVDA
|
$4.03M |
| 2 |
Broadcom
AVGO
|
$3.21M |
| 3 |
Tesla
TSLA
|
$2.65M |
| 4 |
Viking Therapeutics
VKTX
|
$1.64M |
| 5 |
Texas Instruments
TXN
|
$1.6M |
Top Sells
| 1 |
AbbVie
ABBV
|
$27.3M |
| 2 |
Danaher
DHR
|
$16.8M |
| 3 |
Amgen
AMGN
|
$12.2M |
| 4 |
Gilead Sciences
GILD
|
$9.54M |
| 5 |
Regeneron Pharmaceuticals
REGN
|
$7.75M |
Sector Composition
| 1 | Technology | 33.28% |
| 2 | Healthcare | 16.86% |
| 3 | Consumer Discretionary | 11.45% |
| 4 | Communication Services | 8.63% |
| 5 | Energy | 7.43% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
301
Snap
SNAP
$12.4B
| $994K | 0.06% |
88,714
-12,954
| -13% | -$145K |
|
302
Target
TGT
$42.3B
| $991K | 0.06% |
5,985
-1,369
| -19% | -$227K |
|
303
FirstEnergy
FE
$25.1B
| $988K | 0.06% |
24,675
-1,387
| -5% | -$55.6K |
|
304
SAP
SAP
$313B
| $985K | 0.06% |
7,784
+593
| +8% | +$75K |
|
305
Celldex Therapeutics
CLDX
$1.52B
| $985K | 0.06% |
+27,372
| New | +$985K |
|
306
Chubb
CB
$111B
| $981K | 0.06% |
5,050
+317
| +7% | +$61.6K |
|
307
Royal Gold
RGLD
$12.2B
| $980K | 0.06% |
7,555
-707
| -9% | -$91.7K |
|
308
Charles Schwab
SCHW
$167B
| $972K | 0.06% |
18,560
+1,216
| +7% | +$63.7K |
|
|
IMGN
309
DELISTED
Immunogen Inc
IMGN
| $971K | 0.06% |
+252,826
| New | +$971K |
|
310
DTE Energy
DTE
$28.4B
| $963K | 0.06% |
8,795
-496
| -5% | -$54.3K |
|
|
CERE
311
DELISTED
Cerevel Therapeutics Holdings, Inc. Common Stock
CERE
| $959K | 0.06% |
+39,316
| New | +$959K |
|
312
Rocket Pharmaceuticals
RCKT
$354M
| $951K | 0.06% |
+55,516
| New | +$951K |
|
313
DocuSign
DOCU
$16.1B
| $950K | 0.06% |
16,293
-5,137
| -24% | -$299K |
|
314
Jazz Pharmaceuticals
JAZZ
$7.86B
| $947K | 0.06% |
6,475
-532
| -8% | -$77.8K |
|
|
BLUE
315
DELISTED
bluebird bio
BLUE
| $945K | 0.06% |
+14,851
| New | +$945K |
|
316
Immunovant
IMVT
$2.99B
| $938K | 0.06% |
+60,489
| New | +$938K |
|
317
Humana
HUM
$37B
| $934K | 0.06% |
1,923
-130
| -6% | -$63.1K |
|
318
Skyworks Solutions
SWKS
$11.2B
| $933K | 0.06% |
7,906
+1,592
| +25% | +$188K |
|
319
PPL Corp
PPL
$26.6B
| $930K | 0.06% |
33,449
-1,867
| -5% | -$51.9K |
|
320
Krystal Biotech
KRYS
$4.35B
| $927K | 0.06% |
+11,581
| New | +$927K |
|
321
Petrobras Class A
PBR.A
$72.8B
| $922K | 0.06% |
99,314
-3,647
| -4% | -$33.8K |
|
322
Lattice Semiconductor
LSCC
$9.05B
| $921K | 0.06% |
9,643
+723
| +8% | +$69K |
|
323
Editas Medicine
EDIT
$248M
| $912K | 0.06% |
+125,742
| New | +$912K |
|
324
Biohaven
BHVN
$1.68B
| $902K | 0.06% |
+66,008
| New | +$902K |
|
325
America Movil
AMX
$59.1B
| $901K | 0.06% |
42,806
-25
| -0.1% | -$526 |
|